Ireland – Research services – High Throughput Transient Antibody Production and Characterisation Services
- Buyer
- National Institute for Bioprocessing Research and Training (NIBRT)
- Country
- Ireland
- Value
- 375.0k EUR
- Published
- 2026-10-05
- Deadline
- 2026-11-04
- Type
- cn-standard
- Status
- Open to bid
- Category
- CPV 73110000
Description
This Request for Tender (RFT) invites qualified contract research organisations (CROs) and antibody production vendors to submit a technical and commercial proposal for high-throughput antibody production and characterisation services in support of an active discovery programme. This is a research-use programme; GMP manufacture is not required, but the issuing organisation requires vendors to demonstrate data integrity practices aligned with 21 CFR Part 11 principles where reasonably achievable, in line with our internal data governance standards.
The buyer's description as published on TED (Tenders Electronic Daily). The full notice is at the source.
Around this tender
- Closes in 13 days, on 2026-11-04.
- National Institute for Bioprocessing Research and Training (NIBRT) has 3 notices on this site, 2 of them open now, the earliest published 2026-10-01. See them all.
- One of 13 open Research & development tenders in Ireland on this site; where a value is published, the median is 143.1k USD.
- Work under the same CPV group (731) is open in 18 other countries: Poland (18), United Kingdom (14), Belgium (9), Norway (5), Germany (5) and 13 more.
Counted from the notices this site holds, which reach back about a month - not everything a buyer has ever published.
Get new Research and development services and related consultancy tenders in Ireland by email
One free weekly email with the newest matching notices, each with at least a few days left to respond. No account, unsubscribe in one click.
Other open Research & development tenders in Ireland
About this record
This notice was published via TED (Tenders Electronic Daily) and indexed automatically. Figures and dates are reproduced as published at source; always confirm against the original before acting on a deadline.